TheJobsMapSplisense jobs and careers
Jerusalem, Israel
About Splisense
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations. The company has developed a compound to cure the lung disease in cystic fibrosis patients carrying a specific splicing mutation. It is also developing a targeted modulation approach to correct the splicing pattern of CFTRtranscripts according to the specific mutation carried.
Founded in 2016 by Prof. Batsheva Kerem.
- Founded
- 2016
- Employees
- 11 to 50
- Total funding
- $28.5M
- Headquarters
- Jerusalem
Leadership
The top of Splisense's org chart, with how many people report into each leader.
Gili Hart
Chief Executive Officer
6 reports
Lital Friedman
VP Clinical And Regulatory Affairs
3 reports
Ilana Bearman
Executive Assistant To CEO
Asaf Cohen
VP CMC
Jobs at Splisense
No open positions right now. Explore more companies on TheJobsMap.